S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44
S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44
S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44
S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44
NASDAQ:AXLA

Axcella Health News Headlines

$1.45
-0.03 (-2.03%)
(As of 05/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.45
$1.54
50-Day Range
$1.41
$2.82
52-Week Range
$1.35
$5.90
Volume
29,421 shs
Average Volume
84,514 shs
Market Capitalization
$76.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.55
Get Axcella Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for AXLA and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Axcella Health Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AXLA
News Sentiment

0.24

0.48

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AXLA Articles
This Week

4

1

AXLA Articles
Average Week



Axcella Health (NASDAQ:AXLA) News Headlines Today

SourceHeadline
MarketBeat logoAxcella Health (NASDAQ:AXLA) Stock Rating Lowered by Zacks Investment Research
americanbankingnews.com - May 14 at 2:58 AM
MarketBeat logoAxcella Health (NASDAQ:AXLA) Price Target Lowered to $7.00 at Chardan Capital
americanbankingnews.com - May 10 at 4:54 AM
MarketBeat logoShort Interest in Axcella Health Inc. (NASDAQ:AXLA) Declines By 18.1%
americanbankingnews.com - May 6 at 2:46 AM
MarketBeat logoModerna (NASDAQ:MRNA) & Axcella Health (NASDAQ:AXLA) Head to Head Contrast
americanbankingnews.com - May 1 at 1:24 AM
MarketBeat logoAxcella Health Inc. (NASDAQ:AXLA) Given Average Rating of "Buy" by Analysts
americanbankingnews.com - April 26 at 4:24 AM
seekingalpha.com logoAxcella Health: Revisiting A Lottery Ticket
seekingalpha.com - April 25 at 8:15 AM
finance.yahoo.com logoRhythm Pharmaceuticals (RYTM) Down Due to Study Design Changes
finance.yahoo.com - April 7 at 4:26 PM
finance.yahoo.com logoAdverum (ADVM) Up on FDA Feedback for Gene Therapy Study
finance.yahoo.com - April 7 at 4:26 PM
finance.yahoo.com logoAxcella Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
finance.yahoo.com - March 30 at 10:34 AM
benzinga.com logoAxcella Health Earnings Conference Call Is Coming Up, Here's What You Need To Know
benzinga.com - March 24 at 5:49 PM
finance.yahoo.com logoAxcella to Report Fourth Quarter and Year End 2021 Financial Results on March 30, 2022
finance.yahoo.com - March 23 at 11:49 AM
finance.yahoo.com logoWhat Type Of Shareholders Own The Most Number of Axcella Health Inc. (NASDAQ:AXLA) Shares?
finance.yahoo.com - March 17 at 3:43 PM
finance.yahoo.com logoAxcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At The Market
finance.yahoo.com - March 16 at 11:04 AM
finance.yahoo.com logoAxcella Therapeutics Announces FDA Fast Track Designation for AXA1125 in NASH
finance.yahoo.com - February 14 at 10:13 AM
finance.yahoo.com logoAxcella Therapeutics to Participate in the SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 10 at 5:58 PM
finance.yahoo.com logoAxcella Therapeutics Announces Appointment of New Chief Financial Officer
finance.yahoo.com - February 7 at 8:57 AM
finance.yahoo.com logoAxcella Health Inc. (AXLA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
finance.yahoo.com - January 25 at 2:54 PM
nasdaq.com logoAxcella Health Inc Shares Fall 1.5% Below Previous 52-Week Low - Market Mover
nasdaq.com - January 11 at 5:24 AM
seekingalpha.com logoAxcella Health updates on 2022 milestones
seekingalpha.com - January 6 at 1:09 PM
finance.yahoo.com logoAxcella Therapeutics Details Clinical and Operational Milestones for 2022
finance.yahoo.com - January 6 at 8:09 AM
finance.yahoo.com logoAxcella Therapeutics to Present at the H.C. Wainwright BioConnect Conference
finance.yahoo.com - January 4 at 11:03 AM
finance.yahoo.com logoDown 24% in 4 Weeks, Here's Why Axcella Health Inc. (AXLA) Looks Ripe for a Turnaround
finance.yahoo.com - December 30 at 12:30 PM
nasdaq.com logoAxcella Health Inc Shares Fall 0.9% Below Previous 52-Week Low - Market Mover
nasdaq.com - December 28 at 11:27 PM
finance.yahoo.com logoAxcella Kickstarts Long COVID Phase 2 Clinical Trial
finance.yahoo.com - December 16 at 3:52 PM
finance.yahoo.com logoDown 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Axcella Health Inc. (AXLA)
finance.yahoo.com - December 8 at 12:19 PM
finance.yahoo.com logoAxcella Therapeutics Promotes Margaret Koziel, M.D., to Chief Medical Officer
finance.yahoo.com - December 6 at 12:38 PM
nasdaq.com logoWhat You Need To Know About Axcella Health Inc.'s (NASDAQ:AXLA) Investor Composition
nasdaq.com - December 1 at 10:12 AM
finance.yahoo.com logoAxcella Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference
finance.yahoo.com - November 18 at 10:25 AM
finance.yahoo.com logoIs a Surprise Coming for Axcella Health (AXLA) This Earnings Season?
finance.yahoo.com - November 10 at 2:30 PM
finance.yahoo.com logoAxcella Therapeutics Reports Third Quarter Financial Results and Provides Update on Long COVID, OHE and NASH Clinical Trials
finance.yahoo.com - November 10 at 9:27 AM
finance.yahoo.com logoAxcella Therapeutics Announces Upcoming Presentations at AASLD’s The Liver Meeting® 2021
finance.yahoo.com - November 2 at 10:40 AM
finance.yahoo.com logoAxcella To Test NASH Candidate In Long COVID Patients
finance.yahoo.com - October 26 at 2:47 PM
finance.yahoo.com logoAxcella Therapeutics Launches Clinical Program to Develop Treatment for Patients with Long COVID
finance.yahoo.com - October 26 at 9:47 AM
finance.yahoo.com logoFlagship Pioneering spinout thinks it has a treatment for 'long Covid'
finance.yahoo.com - October 26 at 9:47 AM
finance.yahoo.com logoAxcella, Now Axcella Therapeutics, to Host Virtual R&D Day on October 26, 2021
finance.yahoo.com - October 19 at 10:35 AM
nasdaq.com logoAxcella Health Inc Shares Near 52-Week Low - Market Mover
nasdaq.com - October 1 at 3:26 AM
finance.yahoo.com logoAxcella's Leading Drug Candidate for Overt Hepatic Encephalopathy Offers Hope in a Market Requiring Innovation
finance.yahoo.com - September 28 at 2:17 PM
finance.yahoo.com logoAxcella's First-of-Its-Kind NASH Treatment Shows Promising Early Results in Human Trials
finance.yahoo.com - September 9 at 6:17 PM
msn.com logoBRIEF-Axcella Health Inc Says On September 2, Entered Into Loan And Security Agreement With Slr Investment Corp
msn.com - September 7 at 5:31 PM
finance.yahoo.com logoWhat Is The Ownership Structure Like For Axcella Health Inc. (NASDAQ:AXLA)?
finance.yahoo.com - September 2 at 7:42 AM
barrons.com logoAxcella Health Inc.
barrons.com - August 21 at 8:05 AM
finance.yahoo.com logoAxcella Announces Publication in The American Journal of Gastroenterology of Positive Results from AXA1125-003 in Subjects With Presumed NASH
finance.yahoo.com - August 16 at 9:12 AM
seekingalpha.com logoAxcella Health Inc. 2021 Q2 - Results - Earnings Call Presentation
seekingalpha.com - July 30 at 7:29 PM
finance.yahoo.com logoAxcella to Report Second Quarter 2021 Financial Results on July 29, 2021
finance.yahoo.com - July 22 at 8:10 AM
finance.yahoo.com logoAxcella Announces Initiation of EMMPOWER℠ Phase 2 Clinical Trial of AXA1665
finance.yahoo.com - June 30 at 9:34 AM
finance.yahoo.com logoAxcella Accumulating Assets; Multiple Therapies in the Pipeline
finance.yahoo.com - June 13 at 2:40 PM
seekingalpha.com logoAXLA - Axcella Health Inc.
seekingalpha.com - June 11 at 12:28 AM
benzinga.com logoAxcella Health, Aptinyx Shares Spike Higher; Traders Circulate TipRanks Report '2 "Strong Buy" Penny Stocks That Could Rally to $10 (or More)'
benzinga.com - June 10 at 7:27 PM
finance.yahoo.com logoInvaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture
finance.yahoo.com - May 25 at 6:13 AM
benzinga.com logoPositive Clinical Data About Axcella's AXA1665 Candidate for Overt Hepatic Encephalopathy Highlighted in Oral Presentation at DDW 2021
benzinga.com - May 24 at 12:39 PM
Get Axcella Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for AXLA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/17/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.